THERAPEUTIC AGENT FOR SHORT STATURE
The present invention provides: a therapeutic agent for failure to thrive or short stature, which contains type-C natriuretic peptide (CNP) or a CNP derivative as an active ingredient, has reduced adverse side effects, and exhibits excellent drug efficacy; and a treatment method for failure to thriv...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English French Japanese |
Published |
02.08.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides: a therapeutic agent for failure to thrive or short stature, which contains type-C natriuretic peptide (CNP) or a CNP derivative as an active ingredient, has reduced adverse side effects, and exhibits excellent drug efficacy; and a treatment method for failure to thrive or short stature.
La présente invention concerne : un agent thérapeutique pour le retard staturo-pondérale ou la petite taille, qui contient un peptide natriurétique de type C (CNP) ou un dérivé de CNP en tant que principe actif, a des effets secondaires indésirables réduits, et présente une excellente efficacité de médicament ; et un procédé de traitement pour le retard staturo-pondérale ou la petite taille.
本発明は、C型ナトリウム利尿ペプチド(CNP)またはCNP誘導体を有効成分として含有し、副作用を低減し、且つ、優れた薬効を示す成長障害または低身長症の治療剤及び治療方法を提供する。 |
---|---|
Bibliography: | Application Number: WO2018JP02021 |